Arbor Capital Management (Alaska)’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.14M | Buy |
2,546
+606
| +31% | +$272K | 1% | 44 |
|
|
2025
Q1 | $948K | Buy |
1,940
+151
| +8% | +$73.8K | 0.92% | 48 |
|
|
2024
Q4 | $1.02M | Sell |
1,789
-34
| -2% | -$19.4K | 1% | 45 |
|
|
2024
Q3 | $1.12M | Sell |
1,823
-5
| -0.3% | -$3.07K | 1.06% | 45 |
|
|
2024
Q2 | $990K | Sell |
1,828
-106
| -5% | -$57.4K | 0.91% | 47 |
|
|
2024
Q1 | $1.11M | Sell |
1,934
-178
| -8% | -$102K | 1.05% | 47 |
|
|
2023
Q4 | $1.12M | Buy |
2,112
+59
| +3% | +$31.2K | 0.84% | 58 |
|
|
2023
Q3 | $958K | Buy |
2,053
+157
| +8% | +$73.2K | 0.85% | 56 |
|
|
2023
Q2 | $981K | Buy |
1,896
+188
| +11% | +$97.2K | 0.76% | 60 |
|
|
2023
Q1 | $981K | Sell |
1,708
-75
| -4% | -$43.1K | 0.8% | 57 |
|
|
2022
Q4 | $987K | Sell |
1,783
-154
| -8% | -$85.3K | 0.88% | 54 |
|
|
2022
Q3 | $1.04M | Buy |
1,937
+79
| +4% | +$42.4K | 0.94% | 49 |
|
|
2022
Q2 | $1.01M | Sell |
1,858
-26
| -1% | -$14.1K | 0.96% | 53 |
|
|
2022
Q1 | $1.11M | Sell |
1,884
-737
| -28% | -$433K | 0.85% | 59 |
|
|
2021
Q4 | $1.75M | Buy |
+2,621
| New | +$1.75M | 1.24% | 36 |
|